DEUTSCHE BANK AG\ - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 146 filers reported holding VIKING THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,523,449
-22.6%
318,288
+13.4%
0.00%0.0%
Q2 2023$4,550,779
+14.3%
280,739
+17.4%
0.00%0.0%
Q1 2023$3,982,697
+76.0%
239,201
-0.6%
0.00%
+100.0%
Q4 2022$2,262,270
+245.4%
240,6670.0%0.00%
Q3 2022$655,000
-5.9%
240,6670.0%0.00%
Q2 2022$696,000
-16.4%
240,667
-13.4%
0.00%
Q1 2022$833,000
-35.8%
277,797
-1.6%
0.00%
-100.0%
Q4 2021$1,298,000
-26.4%
282,215
+0.4%
0.00%0.0%
Q3 2021$1,764,000
+3.8%
280,954
-0.9%
0.00%0.0%
Q2 2021$1,700,000
-5.8%
283,639
-0.5%
0.00%0.0%
Q1 2021$1,804,000
+43.1%
285,141
+27.3%
0.00%0.0%
Q4 2020$1,261,000
+2.5%
223,947
+6.0%
0.00%0.0%
Q3 2020$1,230,000
-19.8%
211,370
-0.6%
0.00%0.0%
Q2 2020$1,533,000
+94.5%
212,617
+26.2%
0.00%0.0%
Q1 2020$788,000
-42.1%
168,512
-0.8%
0.00%0.0%
Q4 2019$1,361,000
+19.9%
169,904
+2.9%
0.00%0.0%
Q3 2019$1,135,000
-18.6%
165,107
-1.8%
0.00%0.0%
Q2 2019$1,394,000
-18.2%
168,205
-2.1%
0.00%0.0%
Q1 2019$1,705,000
+29.4%
171,757
-0.4%
0.00%0.0%
Q4 2018$1,318,000
-91.0%
172,414
-79.6%
0.00%
-75.0%
Q3 2018$14,720,000
+271.0%
845,120
+102.1%
0.00%
+300.0%
Q2 2018$3,968,000
+198300.0%
418,241
+61861.6%
0.00%
Q1 2018$2,000
-77.8%
675
-70.7%
0.00%
Q4 2017$9,0002,3000.00%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 450,900$2,624,0000.85%
Sio Capital Management, LLC 709,780$4,131,0000.82%
KNOTT DAVID M 218,102$1,269,0000.74%
ArrowMark Colorado Holdings LLC 7,988,635$46,494,0000.44%
Park West Asset Management LLC 1,457,507$8,483,0000.33%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 1,657$10,0000.18%
Virtus ETF Advisers LLC 42,507$247,0000.13%
Cornerstone Capital, Inc. 125,465$730,0000.10%
L & S Advisors Inc 114,988$669,0000.09%
EXANE DERIVATIVES 44,877$261,170,0000.08%
View complete list of VIKING THERAPEUTICS INC shareholders